Award
Delivery Order #SPE2DR26FRRV3
Pharmaceutical Delivery Order for Xolair Syringes to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$11,844.15
Ceiling
$11,844.15
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Apr 01, 2026
Identifier
SPE2DR26FRRV3
NAICS
424210
This award is a delivery order under an existing indefinite delivery vehicle contract for pharmaceutical procurement, aimed at acquiring specific medical supplies. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distributor known for efficient delivery of healthcare products, supporting agency needs reliably. The delivery order focuses on the procurement of Xolair 150 MG/ML syringes, essential for treating specific medical conditions, thereby contributing to effective patient care. The contract highlights the agency's ongoing efforts to maintain a steady supply of critical medications through a well-established supply chain. The scope includes the delivery and supply of the specified pharmaceutical product to the designated location in Park Ridge, IL. This delivery order follows competitive procedures as part of the overarching IDV contract, ensuring best value and compliance with procurement standards. The performance period is brief and specific, covering a multi-week window early in 2026, aligning with the agency's immediate pharmaceutical needs. This award continues the support of the prior, substantial long-term pharmaceutical procurement contract held by DMS Pharmaceutical Group, reinforcing the strategic partnership and continuity in medical supply acquisition.
Description
4571130987!XOLAIR 150 MG/ML SYRINGEML